BlackRock’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.1M Buy
4,590,273
+4,051,813
+752% +$8.87M ﹤0.01% 3363
2025
Q1
$582K Buy
538,460
+94,252
+21% +$102K ﹤0.01% 4311
2024
Q4
$462K Buy
444,208
+12,590
+3% +$13.1K ﹤0.01% 4373
2024
Q3
$540K Buy
431,618
+1,250
+0.3% +$1.56K ﹤0.01% 4255
2024
Q2
$512K Buy
430,368
+152,150
+55% +$181K ﹤0.01% 4287
2024
Q1
$281K Sell
278,218
-1,586
-0.6% -$1.6K ﹤0.01% 4459
2023
Q4
$297K Sell
279,804
-792
-0.3% -$840 ﹤0.01% 4470
2023
Q3
$460K Sell
280,596
-2,772
-1% -$4.55K ﹤0.01% 4383
2023
Q2
$445K Buy
283,368
+21,885
+8% +$34.4K ﹤0.01% 4426
2023
Q1
$374K Buy
261,483
+1,578
+0.6% +$2.26K ﹤0.01% 4524
2022
Q4
$613K Buy
259,905
+3,645
+1% +$8.6K ﹤0.01% 4476
2022
Q3
$517K Sell
256,260
-1,245
-0.5% -$2.51K ﹤0.01% 4626
2022
Q2
$574K Buy
257,505
+4,614
+2% +$10.3K ﹤0.01% 4639
2022
Q1
$1.69M Sell
252,891
-1,953
-0.8% -$13K ﹤0.01% 4374
2021
Q4
$1.41M Buy
254,844
+2,006
+0.8% +$11.1K ﹤0.01% 4473
2021
Q3
$2.32M Buy
252,838
+358
+0.1% +$3.28K ﹤0.01% 4202
2021
Q2
$2.8M Buy
252,480
+925
+0.4% +$10.3K ﹤0.01% 4055
2021
Q1
$2.15M Buy
251,555
+151,131
+150% +$1.29M ﹤0.01% 4204
2020
Q4
$583K Hold
100,424
﹤0.01% 4245
2020
Q3
$266K Hold
100,424
﹤0.01% 4257
2020
Q2
$294K Hold
100,424
﹤0.01% 4215
2020
Q1
$174K Hold
100,424
﹤0.01% 4181
2019
Q4
$432K Buy
100,424
+98,248
+4,515% +$423K ﹤0.01% 4127
2019
Q3
$13K Hold
2,176
﹤0.01% 4641
2019
Q2
$12K Sell
2,176
-160
-7% -$882 ﹤0.01% 4689
2019
Q1
$120K Sell
2,336
-10
-0.4% -$514 ﹤0.01% 4299
2018
Q4
$145K Buy
2,346
+2,092
+824% +$129K ﹤0.01% 4238
2018
Q3
$16K Buy
254
+7
+3% +$441 ﹤0.01% 4615
2018
Q2
$43K Buy
247
+158
+178% +$27.5K ﹤0.01% 4528
2018
Q1
$15K Hold
89
﹤0.01% 4553
2017
Q4
$35K Hold
89
﹤0.01% 4427
2017
Q3
$46K Hold
89
﹤0.01% 4422
2017
Q2
$77K Sell
89
-365
-80% -$316K ﹤0.01% 4381
2017
Q1
$415K Buy
+454
New +$415K ﹤0.01% 3969
2016
Q4
Hold
0
3638